dapiprazole
Trade name: rev-eyes
Small moleculeapproved
Approved
Dec 31, 1990
Dapiprazole is an alpha-1 adrenergic receptors antagonist which was developed for for the treatment of drug induced mydriasis produced by adrenergic or parasympatholytic agents. The drug was marketed under the name Rev-Eyes, however it was withdrawn from market due to its slow effect. — NCATS
Clinical trial activity
0 trials · 0 clinical orgs · 4 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Timeline
1990s
- Dec 31, 1990
Earliest FDA Approval
- Dec 31, 1990
Fera Development, LLC — NDA Secondary Org
2010s
- May 29, 2019
Baradaina LLC — Marketing Organization
- May 29, 2019
Woodward — Marketing Organization
Indications
Approved for
Mechanism of action
- Alpha-1a adrenergic receptorANTAGONIST
ADRA1A antagonist
Approval history
- approvedPriority reviewDec 31, 1990
Chemistry & pharmacology
Loading structure…
SMILES
Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1- Mol. weight
- 325.46 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
- Delivery
- Topical
- Availability
- Discontinued
Oral
No
Parenteral
No
Topical
Yes
Sources
- ChEMBLCHEMBL1201216 ↗
- WikipediaDapiprazole ↗
- NCATS5RNZ8GJO7K ↗
- ChEMBLCHEMBL1201044 ↗
Also known as
- 1,2,4-triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-
- 3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-5,6,7,8,-tetrahydro-1,2,4-triazolo(4,3-a)pyridine hydrochloride
- 5,6,7,8-tetrahydro-3-(2-(4-(o-tolyl)-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine
- 5,6,7,8-tetrahydro-3-(2-(4-(o-tolyl)-1-piperazinyl)ethyl)-s-triazolo(4,3-a)pyridine
- af-2139
- af-2139
- af-2139
- dapiprazol
- dapiprazol
- dapiprazole
- dapiprazole
- dapiprazole
- dapiprazole
- dapiprazole
- dapiprazole
- dapiprazole
- dapiprazole
- dapiprazole hcl
- dapiprazole hcl
- dapiprazole hcl
- dapiprazole hydrochloride
- dapiprazole hydrochloride
- dapiprazole hydrochloride
- dapiprazole hydrochloride
- dapiprazole hydrochloride
- dapiprazole hydrochloride
- dapiprazole hydrochloride
- dapiprazolum
- dapiprazolum
- remydrial
- rev-eyes
- rev-eyes
- rev-eyes
- rev-eyes
Organizations
Marketing (4)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Angelini | For profit | NDA | — |
| Baradaina LLC | For profit | MKTG | May 29, 2019 |
| Fera Development, LLC | For profit | NDA2 | Dec 31, 1990 |
| Woodward | For profit | MKTG | May 29, 2019 |